GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sichuan Biokin Pharmaceutical Co Ltd (SHSE:688506) » Definitions » Change In Receivables

Sichuan Biokin Pharmaceutical Co (SHSE:688506) Change In Receivables : ¥0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Sichuan Biokin Pharmaceutical Co Change In Receivables?

Sichuan Biokin Pharmaceutical Co's change in receivables for the quarter that ended in Mar. 2024 was ¥0 Mil. It means Sichuan Biokin Pharmaceutical Co's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Sichuan Biokin Pharmaceutical Co's change in receivables for the fiscal year that ended in Dec. 2023 was ¥74 Mil. It means Sichuan Biokin Pharmaceutical Co's Accounts Receivable declined by ¥74 Mil from Dec. 2022 to Dec. 2023 .

Sichuan Biokin Pharmaceutical Co's Accounts Receivable for the quarter that ended in Mar. 2024 was ¥95 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Sichuan Biokin Pharmaceutical Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 1.59.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Sichuan Biokin Pharmaceutical Co's liquidation value for the three months ended in Mar. 2024 was ¥4,258 Mil.


Sichuan Biokin Pharmaceutical Co Change In Receivables Historical Data

The historical data trend for Sichuan Biokin Pharmaceutical Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sichuan Biokin Pharmaceutical Co Change In Receivables Chart

Sichuan Biokin Pharmaceutical Co Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.53 78.12 62.89 -142.62 73.60

Sichuan Biokin Pharmaceutical Co Quarterly Data
Dec11 Dec12 Dec13 Dec14 Jun15 Dec18 Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Sichuan Biokin Pharmaceutical Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sichuan Biokin Pharmaceutical Co  (SHSE:688506) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Sichuan Biokin Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=95.291/5462.123*91
=1.59

2. In Ben Graham's calculation of liquidation value, Sichuan Biokin Pharmaceutical Co's accounts receivable are only considered to be worth 75% of book value:

Sichuan Biokin Pharmaceutical Co's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=5825.773-1715.721+0.75 * 95.291+0.5 * 152.891
=4,258

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sichuan Biokin Pharmaceutical Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Sichuan Biokin Pharmaceutical Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Sichuan Biokin Pharmaceutical Co (SHSE:688506) Business Description

Traded in Other Exchanges
N/A
Address
No. 161, Baili Road, No. 1, Building 1, Cross-strait Science and Technology Industrial Park, Wenjiang District, Sichuan Province, Chengdu, CHN, 611130
Sichuan Biokin Pharmaceutical Co Ltd is a chemical drug and biological drug-based company that integrates drug research and development, production and marketing.

Sichuan Biokin Pharmaceutical Co (SHSE:688506) Headlines

No Headlines